Leeward Investments LLC MA Sells 7,843 Shares of Genpact Limited (NYSE:G)

Leeward Investments LLC MA decreased its position in Genpact Limited (NYSE:GFree Report) by 2.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 290,510 shares of the business services provider’s stock after selling 7,843 shares during the quarter. Leeward Investments LLC MA’s holdings in Genpact were worth $10,084,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. GAMMA Investing LLC bought a new stake in shares of Genpact in the 4th quarter worth $43,000. Covestor Ltd grew its position in Genpact by 140.2% during the third quarter. Covestor Ltd now owns 1,549 shares of the business services provider’s stock valued at $56,000 after buying an additional 904 shares during the period. Buck Wealth Strategies LLC increased its holdings in Genpact by 438.3% during the third quarter. Buck Wealth Strategies LLC now owns 1,825 shares of the business services provider’s stock worth $66,000 after buying an additional 1,486 shares during the last quarter. Lindbrook Capital LLC increased its holdings in Genpact by 32.0% during the third quarter. Lindbrook Capital LLC now owns 2,604 shares of the business services provider’s stock worth $94,000 after buying an additional 632 shares during the last quarter. Finally, Flynn Zito Capital Management LLC purchased a new stake in Genpact during the fourth quarter worth about $206,000. Institutional investors own 96.03% of the company’s stock.

Genpact Stock Performance

NYSE:G traded up $0.21 on Friday, reaching $30.90. 1,665,661 shares of the company’s stock were exchanged, compared to its average volume of 1,533,887. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.44 and a quick ratio of 1.44. The firm has a market cap of $5.57 billion, a price-to-earnings ratio of 9.01, a P/E/G ratio of 1.49 and a beta of 1.07. Genpact Limited has a 52 week low of $29.41 and a 52 week high of $44.63. The stock has a fifty day simple moving average of $33.17 and a 200-day simple moving average of $34.16.

Genpact (NYSE:GGet Free Report) last issued its earnings results on Thursday, February 8th. The business services provider reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.03. Genpact had a net margin of 14.10% and a return on equity of 23.19%. The firm had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.12 billion. As a group, sell-side analysts predict that Genpact Limited will post 2.7 earnings per share for the current year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Monday, March 11th were given a $0.153 dividend. This is a positive change from Genpact’s previous quarterly dividend of $0.14. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.98%. The ex-dividend date of this dividend was Friday, March 8th. Genpact’s dividend payout ratio (DPR) is 17.78%.

Analysts Set New Price Targets

A number of analysts recently issued reports on G shares. Mizuho started coverage on shares of Genpact in a report on Tuesday, January 30th. They set a “neutral” rating and a $40.00 price objective for the company. Needham & Company LLC restated a “buy” rating and set a $40.00 price objective on shares of Genpact in a report on Friday, February 9th. Citigroup decreased their price objective on shares of Genpact from $36.00 to $33.00 and set a “neutral” rating for the company in a report on Monday. StockNews.com downgraded shares of Genpact from a “strong-buy” rating to a “buy” rating in a report on Friday, April 5th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Genpact from $42.00 to $43.00 and gave the stock an “underweight” rating in a report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Genpact has a consensus rating of “Hold” and an average price target of $39.78.

Check Out Our Latest Report on Genpact

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.